Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of IV Nalbuphine on PONV Following Intrathecal Morphine
NCT05704673Unknown
- Sponsor
- Assiut University
- Start
- Jun 2023
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
01
Overview
Randomised, double-blind trial of nalbuphine in postoperative nausea and vomiting (PONV) and postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: Postoperative Nausea and Vomiting at 24 hours. Status: unknown.
02
Drugs
nalbuphine
03
Conditions
postoperative nausea and vomiting (PONV)postoperative pain
Beyond the preview
Go deeper on NCT05704673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05704673.